SUBSCRIBE
SUBSCRIBE
News   Business

Angel Biotechnology Ltd to Sell Cramlington Facility, Concentrate Output at Pentlands

June 27, 2007 | 
1 min read
LONDON (Thomson Financial) - Angel Biotechnology Holdings PLC said, following the increased cost burden at its Cramlington facility near Newcastle, it has decided to close and sell it and concentrate production at its Pentlands, Edinburgh, facility.
Real estate Europe
MORE ON THIS TOPIC
Illustration of cardboard box filled with office supplies, a computer keyboard, lamp, and a potted plant
Layoff Tracker
Merck To Cut 125 Employees as It Ends UK R&D Work
September 12, 2025
 · 
198 min read
 · 
BioSpace Editorial Staff
AbbVie headquarters building facade of an American publicly traded biopharmaceutical company. - South San Francisco, California, USA - 2021
Patents
AbbVie Adds Four Years of Exclusivity to Rinvoq Franchise With Generics Settlement
September 12, 2025
 · 
2 min read
 · 
Tristan Manalac
Crisis. Sanctions. Withdrawal of investment and capital. Stop participation. The collapse of the company, the split of business partners.
Autoimmune disease
Intercept Withdraws Embattled Liver Drug from US Market
September 12, 2025
 · 
2 min read
 · 
Tristan Manalac
Glowing red up arrow surrounded by dollar signs in black background. Illustration of the concept of positive return on investment and business earnings
IPO
UPDATE: Neuroscience Biotech LB Pulls Off Upsized $285M IPO
September 11, 2025
 · 
2 min read
 · 
Annalee Armstrong